Psychiatry and Neurology, Neurology · Glendale, CA
NPI
1134433568
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
800 S Central Ave, 307
Glendale, CA, 91204
Phone (818) 646-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$682K
7,925 services
Medicare patients, 2024
941
Average age 73
Drug cost, 2024
$4.1M
8,488 prescriptions
Company payments, 2025
$6,077
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amaiak Chilingaryan was code 99232 (hospital e&m - subsequent), 3,483 times for 81 patients. In total Amaiak Chilingaryan billed 7,925 services in 51 codes, and Medicare paid $682K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 3,483 | 81 | $58.99 | $205K |
| 99215 Office E&M - Established | Office | 956 | 527 | $140.00 | $134K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 876 | 508 | $12.44 | $11K |
| 95886 Electrical Nerve Conductivity | Office | 480 | 185 | $78.00 | $37K |
| 99205 Office E&M - New | Office | 259 | 259 | $170.62 | $44K |
| 99214 Office E&M - Established | Office | 232 | 117 | $99.94 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 185 | 63 | $88.79 | $16K |
| 96132 Behavioral Health Services | Office | 180 | 176 | $98.85 | $18K |
| 96136 Behavioral Health Services | Office | 156 | 152 | $33.22 | $5,182 |
| 95957 Neurologic | Office | 148 | 146 | $238.99 | $35K |
| 95813 Neurologic | Office | 136 | 134 | $368.26 | $50K |
| 95911 Electrical Nerve Conductivity | Office | 124 | 117 | $168.70 | $21K |
| 99483 Office/Outpatient Services | Office | 109 | 108 | $214.69 | $23K |
| 99223 Hospital E&M - Initial | Facility | 76 | 69 | $129.67 | $9,855 |
| 95910 Electrical Nerve Conductivity | Office | 68 | 66 | $140.19 | $9,533 |
By year: 2022 $524K for 4,702 services; 2023 $660K for 6,041 services; 2024 $682K for 7,925 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amaiak Chilingaryan prescribed most often to Medicare patients was Donepezil Hcl, with 993 prescriptions and refills. In total Amaiak Chilingaryan wrote 8,488 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 993 | 1,108 | 147 | $3,249 |
| Memantine Hcl Generic | 883 | 1,006 | 137 | $9,704 |
| Gabapentin Generic | 861 | 898 | 125 | $4,031 |
| Trazodone Hcl Generic | 410 | 437 | 57 | $1,039 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 340 | 401 | 56 | $7,885 |
| Escitalopram Oxalate Generic | 332 | 354 | 52 | $702 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 277 | 280 | 43 | $431K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 221 | 255 | 28 | $2,580 |
| Propranolol Hcl Generic | 216 | 247 | 31 | $1,719 |
| Baclofen Generic | 180 | 191 | 29 | $1,094 |
| Sumatriptan Succinate Generic | 171 | 174 | 25 | $1,031 |
| Rytary Carbidopa/Levodopa | 169 | 194 | 28 | $170K |
| Sertraline Hcl Generic | 168 | 180 | 22 | $244 |
| Primidone Generic | 158 | 170 | 24 | $2,431 |
| Levetiracetam Generic | 151 | 184 | 26 | $3,143 |
Brand drugs: - claims; generic drugs: 6,737 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amaiak Chilingaryan $6,077 ($6,077 in general payments such as food, travel and fees) from 37 companies. The largest payer was UCB, Inc. with $795.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 27 | $795 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $324 |
| SK Life Science, Inc. | 12 | $322 |
| Abbvie Inc. ABBV | 13 | $321 |
| Neurelis, Inc. | 9 | $316 |
| Lundbeck LLC | 11 | $301 |
| Amgen Inc. AMGN | 7 | $283 |
| Amneal Pharmaceuticals LLC AMRX | 10 | $275 |
| ACADIA Pharmaceuticals Inc ACAD | 11 | $247 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $238 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.